Janumet is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It is a combination of two drugs, sitagliptin and metformin, which work together to lower blood sugar levels. Janumet is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of conditions, such as diabetes, thyroid disorders, and obesity. These drugs are used to help regulate hormones and metabolism, and can help improve quality of life for those with these conditions. Some companies in the Janumet market include Merck & Co., Inc., AstraZeneca, and Boehringer Ingelheim. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
